title: American Urological Association Annual Meeting--AUA 2004. 8-13 May 2004, San Francisco, CA, USA.
abstract: Significant areas of new drug development discussed at this year's American Urological Association (AUA) meeting included: antioxidants, immunosuppressants, anti-androgens, kinase inhibitors, immunotherapeutic agents and antitumor vaccines. The poster and podium sessions devoted to urologic neoplasia concentrated on novel drug and vaccine development.
authors.affiliation: Northeastern Ohio Universities College of Medicine, 4209 Street, Route 44, PO Box 95, Rootstown, OH 44272-0095, USA. jmj@neoucom.edu
authors.forename: James
authors.initials: J
authors.lastname: Jamison
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents